发明名称 | Organic compounds | ||
摘要 | The invention relates to compounds and methods of treatment relating to nicotinic receptor antagonists. For example, the compounds and methods of treatment function block the activity of certain acetylcholine receptors and subtypes therein, and are useful treating diseases and conditions mediated by nicotinic receptor stimulation, e.g., small cell lung cancer. | ||
申请公布号 | US9469625(B2) | 申请公布日期 | 2016.10.18 |
申请号 | US201214128378 | 申请日期 | 2012.06.22 |
申请人 | INTRA-CELLULAR THERAPIES, INC. | 发明人 | Li Peng;Peng Youyi;Tomesch John;Wennogle Lawrence P.;Zhang Qiang |
分类号 | A61K31/445;C07D401/12;A61K31/454;A61K31/4745;A61K31/506;A61K33/24;A61K45/06 | 主分类号 | A61K31/445 |
代理机构 | Hoxie & Associates LLC | 代理人 | Hoxie & Associates LLC |
主权项 | 1. A compound of Formula I: wherein R1 is halogen, —SO2NH2, or —COOH; R2 is halogen, —SO2NH2, or —COOH, or H; Y and Z are independently a bond or —CH2—; X is N or CR6; R3 and R6 are independently H, phenyl, tolyl, ethyl or propyl; R5 is independently H, phenyl, tolyl, or lower alkyl; R4 is lower alkyl, or R4 is not present; in free or pharmaceutically acceptable salt form; provided that when R4 is lower alkyl, the compound forms a quaternary ammonium salt and there is an associated pharmaceutically acceptable anion present. | ||
地址 | New York NY US |